First Chinese patent for GILUPI was granted in March 2016

GILUPI detection device for in vivo and/or in vitro enrichment of sample material
First Chinese patent for GILUPI was granted in March 2016 (PresseBox) (Potsdam, ) GILUPI GmbH announced today, that the company received the first Chinese patent protecting the unique and innovative GILUPI technology.
The patent (ZL201080027208.2) titles “detection device for in vivo and/or in vitro enrichment of sample material” describes a functionalized structured medical wire for the accumulation of sample material. The device comprising a biocompatible polymer and a functional surface equipped with detection receptors which for example enables the isolation of cells directly from the blood of patients (in vivo). This patented technology is already being used in clinical settings on national and international level.
The recently received patent is an important supplementation of GILUPI`s intellectual property portfolio. Thus, the company has a broad and strong intellectual property position required to run the GILUPI businesses. GILUPI has filed further patent applications that are currently subject to examination procedures for a number of inventions, hence further granted patents will follow soon.

Kontakt

GILUPI GmbH
Hermannswerder 20a
D-14473 Potsdam
Dr. Claudia Chudak
Marketing & Sales Application Specialist

Bilder

Social Media